Childhood influenza vaccination coverage--United States, 2003-04 influenza season

    Insights

    Influenza vaccination coverage for young children increased in 2003-04 but remained low. The Advisory Committee on Immunization Practices (ACIP) recommended annual flu shots for children aged 6-23 months and their contacts.

    Area of Science:

    • Pediatric Infectious Diseases
    • Public Health Policy
    • Vaccinology

    Background:

    • Young children under 2 years face a higher risk of hospitalization due to influenza.
    • Influenza vaccination recommendations for children aged 6-23 months and their contacts were introduced in 2002 and strengthened in 2004-05 by the Advisory Committee on Immunization Practices (ACIP).
    • Specific high-risk groups, including children with medical conditions or on aspirin therapy, are also recommended for annual influenza vaccination.

    Purpose of the Study:

    • To assess childhood influenza vaccination coverage during the 2003-04 influenza season.
    • To evaluate the impact of the Advisory Committee on Immunization Practices (ACIP) encouragement for vaccinating children aged 6-23 months and their contacts.
    • To identify trends and variations in pediatric influenza vaccination rates.

    Main Methods:

    • Analysis of childhood influenza vaccination coverage data for the 2003-04 season.
    • Comparison of coverage rates with the previous influenza season.
    • Examination of state and urban area variability in vaccination uptake.

    Main Results:

    • Influenza vaccination coverage among young children showed an increase compared to the prior season.
    • Despite the increase, overall vaccination coverage remained low.
    • Significant disparities in vaccination coverage were observed across different states and urban areas.

    Conclusions:

    • While progress was made, pediatric influenza vaccination coverage requires further improvement.
    • Targeted interventions may be necessary to address the low uptake and geographic variability in vaccination rates.
    • Continued monitoring and policy evaluation are essential to enhance influenza protection for young children.

    Related Concept Videos

    Vaccinations01:51

    Vaccinations

    Overview
    Influenza01:27

    Influenza

    Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
    Smallpox01:24

    Smallpox

    Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
    Chickenpox01:20

    Chickenpox

    Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
    Poliomyelitis01:17

    Poliomyelitis

    Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
    Respiratory Syncytial Virus Disease01:29

    Respiratory Syncytial Virus Disease

    Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...